What is Embecta Price-to-Operating-Cash-Flow?
As of today (2024-05-20), Embecta's share price is $14.51.
Embecta's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.54. Hence, Embecta's Price-to-Operating-Cash-Flow Ratio for today is 26.77.
The historical rank and industry rank for Embecta's Price-to-Operating-Cash-Flow or its related term are showing as below:
EMBC'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.51 Med: 5.74 Max: 26.81
Current: 26.75
During the past 5 years, Embecta's highest Price-to-Operating-Cash-Flow Ratio was 26.81. The lowest was 3.51. And the median was 5.74.
Embecta's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was $0.42.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.54.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Embecta was -77.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -48.80% per year.
During the past 5 years, Embecta's highest 3-Year average Operating Cash Flow per Share Growth Rate was -6.80% per year. The lowest was -48.80% per year. And the median was -27.80% per year.
Embecta Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Embecta's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embecta Price-to-Operating-Cash-Flow Chart
|
Embecta Annual Data
|
|
Trend |
Sep19 |
Sep20 |
Sep21 |
Sep22 |
Sep23 |
| Price-to-Operating-Cash-Flow |
|
- |
- |
- |
4.01 |
12.84 |
|
Embecta Quarterly Data
|
|
Sep19 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
11.53 |
12.61 |
12.84 |
- |
24.48 |
Competitive Comparison of Embecta's Price-to-Operating-Cash-Flow
For the Medical Instruments & Supplies subindustry, Embecta's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embecta's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Embecta's Price-to-Operating-Cash-Flow falls into.
Embecta Price-to-Operating-Cash-Flow Calculation
Embecta's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 14.51 | / | 0.542 |
| = | 26.77 |
Embecta's Share Price of today is $14.51.
Embecta's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.54.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Embecta (Embecta) Business Description
Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Executives
| David F Melcher |
director |
1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102 |
| Devdatt Kurdikar |
officer: President and CEO |
ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
| Jacob Elguicze |
officer: Chief Financial Officer |
ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
| Jeffrey Z Mann |
officer: SVP, GC, Head Corp. Dev., Secy |
150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
| Jean Casner |
officer: Chief Human Resources Officer |
150 CLOVE ROAD, LITTLE FALLS NJ 07424 |
| Karen Prange |
director |
1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316 |
| Ajay Kumar |
officer: SVP and CHRO |
C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
| Shaun Curtis |
officer: SVP, Global Manuf./Sup. Chain |
C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
| David Albritton |
director |
ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417-1880 |
| Milton Mayo Morris |
director |
2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019 |
| Brian Capone |
officer: VP, CAO & Corp. Controller |
150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
| Carrie L Anderson |
director |
3005 HIGHLAND PARKWAY, SUITE 200, DOWNERS GROVE IL 60515 |
| Claire Pomeroy |
director |
BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
| Christopher R Reidy |
director |
ONE ADP BLVD, ROSELAND NJ 07068 |
| Robert J. Hombach |
director |
C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015 |
Embecta (Embecta) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EMBC has been successfully added to your